Kidney Transplant Market by Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By Target Area (Stomach, Esophagus, Large Intestine, Small Intestine), By End-User (Hospitals, Clinics, Research Institutes), and Geography.

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Kidney transplant or renal transplant is transplantation of kidney to the end-stage renal disease (ESRD). Based on the donor kidney transplantation is classified into deceased donor or living donor transplantation. Kidney transplant gained widespread popularity by improving outcome of ESRD patients..In April 2017, Sanofi received FDA approval of Thymoglobulin used in preventiuon of acute kidney transplant rejection.Kidney transplantation is the most common type of transplant surgery performed around the world. It has earned significant acclaim for improving the outcomes of patients with end-stage renal disease (ESRD). Renal transplantation is now commonly regarded as the best technique to treat chronic kidney disease for many people, thanks to advancements in kidney transplant technologies and improved transplant success. As the number of organ donors rises, the number of transplant surgeries will rise as well. However, because of the higher cost of procedures, a market shift is envisaged in Asian countries where medical tourism is pushed. Analysis of Kidney Transplants Performed: In 2015, the United States accounted for more than 40% of all kidney transplants performed.

 

Kidney Transplant Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

North America

Fastest Growing Market

Europe
Growth

Kidney transplant market is witnessed to grow at a significant CAGR owing to advancements in the kidney transplantation methods and increase in success rate of kidney transplants. Moreover, rise in prevalence of end stage renal disease (ESRD), increase in the number of deceased kidney donors, and sophisticated healthcare infrastructure are anticipated to fuel the kidney transplant market over the forecast years. However, high cost of kidney transplant procedure and adverse effects associated with organ transplantation are expected to restrain the growth of kidney transplant market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Kidney Transplant Market Segmentation

Application
  • Drug Delivery,
  • Capsule Endoscopy,
  • Patient Monitoring
Target Area
  • Stomach,
  • Esophagus,
  • Large Intestine,
  • Small Intestine
End-User
  • Hospitals,
  • Clinics,
  • Research Institutes

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Table of Content 1. Executive Summary 2. Global Kidney Transplant Market Introduction 2.1. Global Kidney Transplant Market – Taxonomy 2.2. Global Kidney Transplant Market –Definitions 2.2.1. Immunosuppressive/rejection Drugs 2.2.2. Distribution Channel 3. Global Kidney Transplant Market Dynamics 3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Kidney Transplant Market Dynamic Factors - Impact Analysis 3.6. Global Kidney Transplant Market – Competition Landscape 3.7. Epidemiology 4. Global Kidney Transplant Market Analysis,2013 - 2017 and Forecast, 2018 – 2024 4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market OpportunityAnalysis 5. Global Kidney Transplant Market, By Immunosuppressive/rejection Drugs, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.1. Prograf (Tacrolimus) 5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.1.3. Market Opportunity Analysis 5.2. Myfortic (Mycophenolic Acid) 5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.2.3. Market Opportunity Analysis 5.3. Cellcept (Mycophenolate Mofetil) 5.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.3.3. Market Opportunity Analysis 5.4. Zortress / Certican (Everolimus) 5.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.4.3. Market Opportunity Analysis 5.5. Rapamune (Sirolimus) 5.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.5.3. Market Opportunity Analysis 5.6. Neoral / Sandimmune (Cyclosporine) 5.6.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 5.6.3. Market Opportunity Analysis 6. Global Kidney Transplant Market Forecast, By Distribution Channel,2013 - 2017 and Forecast, 2018 – 2024 6.1. Hospital Pharmacies 6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Retail Pharmacies 6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 6.3. Online Stores 6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.3.3. Market Opportunity Analysis 7. Global Kidney Transplant Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.1. North America 7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Europe 7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Asia-Pacific 7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 7.4. Latin America 7.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.4.3. Market Opportunity Analysis 7.5. Middle East and Africa 7.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.5.3. Market Opportunity Analysis 7.6. Global Kidney Transplant Market - Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Region, 2018 – 2024 8. North America Kidney Transplant MarketAnalysis,2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 8.1. Immunosuppressive/rejection Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 8.1.1. Prograf (Tacrolimus) 8.1.2. Myfortic (Mycophenolic Acid) 8.1.3. Cellcept (Mycophenolate Mofetil) 8.1.4. Zortress / Certican (Everolimus) 8.1.5. Rapamune (Sirolimus) 8.1.6. Neoral / Sandimmune (Cyclosporine) 8.2. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 8.2.1. Hospital Pharmacies 8.2.2. Retail Pharmacies 8.2.3. Online Stores 8.3. Country Analysis 2016 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 8.3.1. U.S. 8.3.2. Canada 8.4. North America Kidney Transplant Market - Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024 8.5. North America Kidney Transplant Market Dynamics – Trends 9. Europe Kidney Transplant Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 9.1. Immunosuppressive/rejection Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 9.1.1. Prograf (Tacrolimus) 9.1.2. Myfortic (Mycophenolic Acid) 9.1.3. Cellcept (Mycophenolate Mofetil) 9.1.4. Zortress / Certican (Everolimus) 9.1.5. Rapamune (Sirolimus) 9.1.6. Neoral / Sandimmune (Cyclosporine) 9.2. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.2.1. Hospital Pharmacies 9.2.2. Retail Pharmacies 9.2.3. Online Stores 9.3. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 9.3.1. Germany 9.3.2. UK 9.3.3. France 9.3.4. Spain 9.3.5. Italy 9.3.6. Russia 9.3.7. Poland 9.3.8. Rest of Europe 9.4. Europe Kidney Transplant Market - Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024 9.5. Europe Kidney Transplant Market Dynamics – Trends 10. Asia-Pacific Kidney Transplant Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 10.1. Immunosuppressive/rejection Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 10.1.1. Prograf (Tacrolimus) 10.1.2. Myfortic (Mycophenolic Acid) 10.1.3. Cellcept (Mycophenolate Mofetil) 10.1.4. Zortress / Certican (Everolimus) 10.1.5. Rapamune (Sirolimus) 10.1.6. Neoral / Sandimmune (Cyclosporine) 10.2. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.2.1. Hospital Pharmacies 10.2.2. Retail Pharmacies 10.2.3. Online Stores 10.3. Country Analysis2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.3.1. Japan 10.3.2. China 10.3.3. India 10.3.4. ASEAN 10.3.5. Australia & New Zealand 10.3.6. Rest of Asia-Pacific 10.4. Asia-Pacific Kidney Transplant Market - Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024 10.5. Asia-Pacific Kidney Transplant Market Dynamics – Trends 11. Latin America Kidney Transplant Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 11.1. Immunosuppressive/rejection Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 11.1.1. Prograf (Tacrolimus) 11.1.2. Myfortic (Mycophenolic Acid) 11.1.3. Cellcept (Mycophenolate Mofetil) 11.1.4. Zortress / Certican (Everolimus) 11.1.5. Rapamune (Sirolimus) 11.1.6. Neoral / Sandimmune (Cyclosporine) 11.2. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.2.1. Hospital Pharmacies 11.2.2. Retail Pharmacies 11.2.3. Online Stores 11.3. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.3.1. Brazil 11.3.2. Mexico 11.3.3. Argentina 11.3.4. Venezuela 11.3.5. Rest of Latin America 11.4. Latin America Kidney Transplant Market - Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024 11.5. Latin America Kidney Transplant Market Dynamics – Trends 12. Middle East and Africa Kidney Transplant Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn) 12.1. Immunosuppressive/rejection Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 12.1.1. Prograf (Tacrolimus) 12.1.2. Myfortic (Mycophenolic Acid) 12.1.3. Cellcept (Mycophenolate Mofetil) 12.1.4. Zortress / Certican (Everolimus) 12.1.5. Rapamune (Sirolimus) 12.1.6. Neoral / Sandimmune (Cyclosporine) 12.2. Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.2.1. Hospital Pharmacies 12.2.2. Retail Pharmacies 12.2.3. Online Stores 12.3. Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 12.3.1. Gulf Cooperation Council (GCC) Countries 12.3.2. Israel 12.3.3. South Africa 12.3.4. Rest of MEA 12.4. MEA Kidney Transplant Market - Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024 12.5. MEA Kidney Transplant Market Dynamics – Trends 13. Competition Landscape 13.1. Strategic Dashboard of Top Market Players 13.2. Company Profiles (Introduction, Financial Analysis, Immunosuppressive/rejection Drugs& Service Offerings, Key Developments, Strategies, and SWOT Analysis) 13.2.1. Veloxis Pharmaceuticals A/S (Denmark) 13.2.2. Sanofi (France) 13.2.3. Immucor, Inc. (U.S) 13.2.4. Biocon Ltd. (India) 13.2.5. Novartis AG (Switzerland) 13.2.6. Pfizer, Inc. (U.S.) 13.2.7. Astellas Pharma (U.S.) 13.2.8. Hoffmann La Roche Ltd. (Switzerland) 14. Research Methodology 15. Key Assumptions and Acronyms
  • Veloxis Pharmaceuticals A/S (Denmark)
  • Sanofi (France)
  • Immucor, Inc. (U.S)
  • Biocon Ltd. (India)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • Astellas Pharma (U.S.)
  • Hoffmann La Roche Ltd. (Switzerland)